151 related articles for article (PubMed ID: 16387369)
61. C6-peptide serology as diagnostic tool in neuroborreliosis.
Tjernberg I; Schön T; Ernerudh J; Wistedt AC; Forsberg P; Eliasson I
APMIS; 2008 May; 116(5):393-9. PubMed ID: 18452429
[TBL] [Abstract][Full Text] [Related]
62. Evaluation of an internally controlled real-time PCR targeting the ospA gene for detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid.
Gooskens J; Templeton KE; Claas EC; van Dam AP
Clin Microbiol Infect; 2006 Sep; 12(9):894-900. PubMed ID: 16882295
[TBL] [Abstract][Full Text] [Related]
63. The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study.
Tetens MM; Dessau R; Ellermann-Eriksen S; Andersen NS; Jørgensen CS; Østergaard C; Bodilsen J; Damgaard DF; Bangsborg J; Nielsen AC; Møller JK; Omland LH; Obel N; Lebech AM
Clin Microbiol Infect; 2022 Nov; 28(11):1500.e1-1500.e6. PubMed ID: 35709901
[TBL] [Abstract][Full Text] [Related]
64. Spontaneous brain hemorrhage associated with Lyme neuroborreliosis.
Seijo Martínez M; Grandes Ibáñez J; Sánchez Herrero J; García-Moncó JC
Neurologia; 2001 Jan; 16(1):43-5. PubMed ID: 11234662
[TBL] [Abstract][Full Text] [Related]
65. [Acute severe leukoencephalitis with posterior lesions due to Borrelia burgdorferi infection].
Drouet A; Meyer X; Guilloton L; Mullet JP; Dusseau JY; Denoyel GA; Felten D
Presse Med; 2003 Oct; 32(34):1607-9. PubMed ID: 14576583
[TBL] [Abstract][Full Text] [Related]
66. [Lymphadenopathy and absences].
Staub E; Strozzi S; Aebi C
Praxis (Bern 1994); 2007 May; 96(20):815-7. PubMed ID: 17566418
[TBL] [Abstract][Full Text] [Related]
67. Effect of passive immunoglobulin transfer on results of diagnostic tests for antibodies against Borrelia burgdorferi in pups born to a seropositive dam.
Eschner AK
Vet Ther; 2008; 9(3):184-91. PubMed ID: 19003779
[TBL] [Abstract][Full Text] [Related]
68. Anti-inflammatory effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in neuronal cultures of dorsal root ganglia and myelinating cells of the peripheral nervous system.
Ramesh G; Meisner OC; Philipp MT
J Neuroinflammation; 2015 Dec; 12():240. PubMed ID: 26700298
[TBL] [Abstract][Full Text] [Related]
69. The pathogenesis of lyme neuroborreliosis: from infection to inflammation.
Rupprecht TA; Koedel U; Fingerle V; Pfister HW
Mol Med; 2008; 14(3-4):205-12. PubMed ID: 18097481
[TBL] [Abstract][Full Text] [Related]
70. Quantitative serological antibody testing for suspected neuroborreliosis.
Schneider C; Gielen J; Röth P; Albrecht P; Schroeter M; Fink GR; Wunderlich G; Lehmann HC
J Neurol; 2020 May; 267(5):1476-1481. PubMed ID: 32008071
[TBL] [Abstract][Full Text] [Related]
71. Pathogen specificity and autoimmunity are distinct features of antigen-driven immune responses in neuroborreliosis.
Kuenzle S; von Büdingen HC; Meier M; Harrer MD; Urich E; Becher B; Goebels N
Infect Immun; 2007 Aug; 75(8):3842-7. PubMed ID: 17517881
[TBL] [Abstract][Full Text] [Related]
72. IgE anti-Borrelia burgdorferi components (p18, p31, p34, p41, p45, p60) and increased blood CD8+CD60+ T cells in children with Lyme disease.
Bluth MH; Robin J; Ruditsky M; Norowitz KB; Chice S; Pytlak E; Nowakowski M; Durkin HG; Smith-Norowitz TA
Scand J Immunol; 2007 Apr; 65(4):376-82. PubMed ID: 17386029
[TBL] [Abstract][Full Text] [Related]
73. Toll-like receptors: insights into their possible role in the pathogenesis of lyme neuroborreliosis.
Bernardino AL; Myers TA; Alvarez X; Hasegawa A; Philipp MT
Infect Immun; 2008 Oct; 76(10):4385-95. PubMed ID: 18694963
[TBL] [Abstract][Full Text] [Related]
74. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
Glatz M; Golestani M; Kerl H; Müllegger RR
Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
[TBL] [Abstract][Full Text] [Related]
75. Ocular flutter as the first manifestation of Lyme disease.
Gyllenborg J; Milea D
Neurology; 2009 Jan; 72(3):291. PubMed ID: 19153379
[No Abstract] [Full Text] [Related]
76. [Clinical polymorphism of neuroborreliosis at a late stage of the disease].
Vel'gin SO; Protas II; Ponomarev VV; Drakina SA; Shcherba VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):48-51. PubMed ID: 16608111
[No Abstract] [Full Text] [Related]
77. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134
[TBL] [Abstract][Full Text] [Related]
78. Sublime diagnosis of Lyme neuroborreliosis.
Segal BM; Logigian EL
Neurology; 2005 Aug; 65(3):351-2. PubMed ID: 16087895
[No Abstract] [Full Text] [Related]
79. Neuroborreliosis in an HIV-1 positive patient.
Cerný R; Machala L; Bojar M; Rozsypal H; Pícha D
Infection; 2006 Apr; 34(2):100-2. PubMed ID: 16703302
[TBL] [Abstract][Full Text] [Related]
80. Lyme neuroborreliosis: infection, immunity, and inflammation.
Pachner AR; Steiner I
Lancet Neurol; 2007 Jun; 6(6):544-52. PubMed ID: 17509489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
